Arbutus Biopharma Corp. (ABUS)
5.14
+0.05
(+0.98%)
USD |
NASDAQ |
Sep 02, 10:40
Arbutus Biopharma Research and Development Expense (Annual) : 25.24M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 25.24M |
| December 31, 2024 | 54.04M |
| December 31, 2023 | 73.70M |
| December 31, 2022 | 84.41M |
| December 31, 2021 | 65.50M |
| December 31, 2020 | 47.48M |
| December 31, 2019 | 57.60M |
| December 31, 2018 | 57.95M |
| December 31, 2017 | 62.68M |
| December 31, 2016 | 55.25M |
| December 31, 2015 | 47.30M |
| December 31, 2014 | 38.71M |
| December 31, 2013 | 21.46M |
| December 31, 2012 | 18.04M |
| December 31, 2011 | 20.11M |
| Date | Value |
|---|---|
| December 31, 2010 | 21.49M |
| December 31, 2009 | 15.58M |
| December 31, 2008 | 15.11M |
| December 31, 2007 | 7.777M |
| December 31, 2006 | 4.680M |
| December 31, 2005 | 8.534M |
| December 31, 2004 | 20.89M |
| December 31, 2003 | 21.95M |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | |
| December 31, 1999 | 7.552M |
| December 31, 1998 | 8.970M |
| December 31, 1997 | 6.492M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Moderna, Inc. | 2.917B |
| Insmed, Inc. | 771.09M |
| Pfizer Inc. | 10.25B |
| Gossamer Bio, Inc. | 174.07M |
| Legend Biotech Corp. | 415.80M |